BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nakase H, Uchino M, Shinzaki S, Matsuura M, Matsuoka K, Kobayashi T, Saruta M, Hirai F, Hata K, Hiraoka S, Esaki M, Sugimoto K, Fuji T, Watanabe K, Nakamura S, Inoue N, Itoh T, Naganuma M, Hisamatsu T, Watanabe M, Miwa H, Enomoto N, Shimosegawa T, Koike K. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. J Gastroenterol 2021;56:489-526. [PMID: 33885977 DOI: 10.1007/s00535-021-01784-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Lertpairod J, Tiyaboonchai W. pH-sensitive beads containing curcumin loaded nanostructured lipid carriers for a colon targeted oral delivery system. J Pharm Investig . [DOI: 10.1007/s40005-022-00572-0] [Reference Citation Analysis]
2 Wang S, Huang J, Liu F, Tan KS, Deng L, Lin Y, Tan W. Isosteviol Sodium Exerts Anti-Colitic Effects on BALB/c Mice with Dextran Sodium Sulfate-Induced Colitis Through Metabolic Reprogramming and Immune Response Modulation. J Inflamm Res 2021;14:7107-30. [PMID: 34992409 DOI: 10.2147/JIR.S344990] [Reference Citation Analysis]
3 Dowdell AS, Colgan SP. Metabolic Host-Microbiota Interactions in Autophagy and the Pathogenesis of Inflammatory Bowel Disease (IBD). Pharmaceuticals (Basel) 2021;14:708. [PMID: 34451805 DOI: 10.3390/ph14080708] [Reference Citation Analysis]
4 Rolak S, Kane SV. Conventional Therapies for Crohn's Disease. Gastroenterol Clin North Am 2022;51:271-82. [PMID: 35595414 DOI: 10.1016/j.gtc.2021.12.004] [Reference Citation Analysis]
5 Ren J, Yan D, Wang Y, Zhang J, Li M, Xiong W, Jing X, Li P, Zhao W, Xiong X, Wu M, Zhong G. Inhibitor of Differentiation-2 Protein Ameliorates DSS-Induced Ulcerative Colitis by Inhibiting NF-κB Activation in Neutrophils. Front Immunol 2021;12:760999. [PMID: 34804049 DOI: 10.3389/fimmu.2021.760999] [Reference Citation Analysis]
6 Matsuoka K, Nagano K, Nagasaki S, Murata Y, Hisamatsu T. Symptom Improvement of ulceRative colitis after an Induction dose of UStekinumab in Japanese clinical practice (SIRIUS), measured using patient-reported outcomes: a prospective observational study. BMJ Open 2022;12:e060081. [PMID: 35508346 DOI: 10.1136/bmjopen-2021-060081] [Reference Citation Analysis]
7 Lee YJ. Is Paradigm for the Role of Balloon-Assisted Enteroscopy Changing in Crohn's Disease? Gut Liver 2021;15:325-6. [PMID: 33988130 DOI: 10.5009/gnl210194] [Reference Citation Analysis]
8 Zhou C, Zhou H, Zhang F, Hao L, Guo J. Active Ingredients and Potential Mechanisms of the Gan Jiang-Huang Qin-Huang Lian-Ren Shen Decoction against Ulcerative Colitis: A Network Pharmacology and Molecular Docking-Based Study. Evid Based Complement Alternat Med 2021;2021:1925718. [PMID: 34539797 DOI: 10.1155/2021/1925718] [Reference Citation Analysis]
9 Wang S, Huang J, Tan KS, Deng L, Liu F, Tan W, Dominguez Perles R. Isosteviol Sodium Ameliorates Dextran Sodium Sulfate-Induced Chronic Colitis through the Regulation of Metabolic Profiling, Macrophage Polarization, and NF-κB Pathway. Oxidative Medicine and Cellular Longevity 2022;2022:1-16. [DOI: 10.1155/2022/4636618] [Reference Citation Analysis]
10 Hong L, Chen G, Cai Z, Liu H, Zhang C, Wang F, Xiao Z, Zhong J, Wang L, Wang Z, Cui W. Balancing Microthrombosis and Inflammation via Injectable Protein Hydrogel for Inflammatory Bowel Disease. Adv Sci (Weinh) 2022;:e2200281. [PMID: 35524641 DOI: 10.1002/advs.202200281] [Reference Citation Analysis]
11 Shi JL, Lv YH, Huang J, Huang X, Liu Y. Patients with inflammatory bowel disease and post-inflammatory polyps have an increased risk of colorectal neoplasia: A meta-analysis. World J Clin Cases 2022; 10(3): 966-984 [DOI: 10.12998/wjcc.v10.i3.966] [Reference Citation Analysis]
12 Xu F, Hu J, Yang Q, Ji Y, Cheng C, Zhu L, Shen H. Prevalence and factors associated with fatigue in patients with ulcerative colitis in China: a cross-sectional study. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02357-z] [Reference Citation Analysis]
13 Zhou T, Sheng Y, Guan H, Meng R, Wang Z. Cost-Effectiveness Analysis of Vedolizumab Compared With Infliximab in Anti-TNF-α-Naïve Patients With Moderate-to-Severe Ulcerative Colitis in China. Front Public Health 2021;9:704889. [PMID: 34490187 DOI: 10.3389/fpubh.2021.704889] [Reference Citation Analysis]
14 Miyoshi J, Ozaki R, Yonezawa H, Mori H, Kawamura N, Matsuura M, Hisamatsu T. Ratio of submucosal thickness to total bowel wall thickness as a new sonographic parameter to estimate endoscopic remission of ulcerative colitis. J Gastroenterol. [DOI: 10.1007/s00535-021-01847-3] [Reference Citation Analysis]
15 Ihara K, Isono H, Isono M, Akaiwa Y, Kobayashi K, Oogi M, Oogi T. Cytomegalovirus colitis with a new diagnosis of ulcerative colitis in an elderly woman. J Rural Med 2022;17:85-8. [DOI: 10.2185/jrm.2021-053] [Reference Citation Analysis]
16 Moreno LO, Fernández-tomé S, Abalo R. Biological Treatments in Inflammatory Bowel Disease: A Complex Mix of Mechanisms and Actions. Biologics 2021;1:189-210. [DOI: 10.3390/biologics1020012] [Reference Citation Analysis]
17 Nakase H, Hayashi Y, Hirayama D, Matsumoto T, Matsuura M, Iijima H, Matsuoka K, Ohmiya N, Ishihara S, Hirai F, Abukawa D, Hisamatsu T; J-COSMOS group. Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS). J Gastroenterol 2022. [PMID: 35089397 DOI: 10.1007/s00535-022-01851-1] [Reference Citation Analysis]
18 Amarnani A, Thakker S, Panush RS. Reflecting on the immunopathology of arthritis associated with inflammatory bowel disease: what do we know and what should we know? Clin Rheumatol 2022. [PMID: 35543893 DOI: 10.1007/s10067-022-06201-3] [Reference Citation Analysis]
19 Tsujii Y, Nishida T, Osugi N, Fujii Y, Sugimoto A, Nakamatsu D, Mukai K, Matsumoto K, Hayashi S, Yamamoto M, Nakajima S. Classification and clinical features of adverse drug reactions in patients with ulcerative colitis treated with 5-aminosalicylate acid: a single-center, observational study. Scand J Gastroenterol 2021;:1-7. [PMID: 34751626 DOI: 10.1080/00365521.2021.1998601] [Reference Citation Analysis]
20 Wang JM, Lin SR, Zhu YB, Yuan J, Wang YM, Zhang Q, Xie LS, Li SH, Liu SQ, Yu SG, Wu QF. Proteomic analysis of lysine acetylation reveals that metabolic enzymes and heat shock proteins may be potential targets for DSS-induced mice colitis. Int Immunopharmacol 2021;101:108336. [PMID: 34768127 DOI: 10.1016/j.intimp.2021.108336] [Reference Citation Analysis]
21 Paudel MS, Khanal A, Shrestha B, Purbey B, Paudel BN, Shrestha G, Thapa J, Dewan KR, Gurung R, Joshi N. Epidemiology of Inflammatory Bowel Diseases in Nepal. Cureus 2021;13:e16692. [PMID: 34466323 DOI: 10.7759/cureus.16692] [Reference Citation Analysis]
22 Wnorowski A, Wnorowska S, Kurzepa J, Parada-Turska J. Alterations in Kynurenine and NAD+ Salvage Pathways during the Successful Treatment of Inflammatory Bowel Disease Suggest HCAR3 and NNMT as Potential Drug Targets. Int J Mol Sci 2021;22:13497. [PMID: 34948292 DOI: 10.3390/ijms222413497] [Reference Citation Analysis]
23 Andoh A, Kawahara M, Imai T, Tatsumi G, Inatomi O, Kakuta Y. Thiopurine pharmacogenomics and pregnancy in inflammatory bowel disease. J Gastroenterol 2021. [PMID: 34287682 DOI: 10.1007/s00535-021-01805-z] [Reference Citation Analysis]
24 Yin J, Wei L, Wang N, Li X, Miao M. Efficacy and safety of adjuvant curcumin therapy in ulcerative colitis: A systematic review and meta-analysis. Journal of Ethnopharmacology 2022. [DOI: 10.1016/j.jep.2022.115041] [Reference Citation Analysis]
25 Kordulewska NK, Topa J, Rozmus D, Jarmołowska B. Effects of Osthole on Inflammatory Gene Expression and Cytokine Secretion in Histamine-Induced Inflammation in the Caco-2 Cell Line. Int J Mol Sci 2021;22:13634. [PMID: 34948440 DOI: 10.3390/ijms222413634] [Reference Citation Analysis]
26 Hirayama H, Morita Y, Imai T, Takahashi K, Yoshida A, Bamba S, Inatomi O, Andoh A. Ustekinumab trough levels predicting laboratory and endoscopic remission in patients with Crohn's disease. BMC Gastroenterol 2022;22:195. [PMID: 35448957 DOI: 10.1186/s12876-022-02271-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Li M, Weigmann B. A Novel Pathway of Flavonoids Protecting against Inflammatory Bowel Disease: Modulating Enteroendocrine System. Metabolites 2022;12:31. [PMID: 35050153 DOI: 10.3390/metabo12010031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Wang K, Guo J, Chang X, Gui S. Painong-San extract alleviates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota, restoring intestinal barrier function and attenuating TLR4/NF-κB signaling cascades. J Pharm Biomed Anal 2021;209:114529. [PMID: 34915325 DOI: 10.1016/j.jpba.2021.114529] [Reference Citation Analysis]
29 Miyoshi J, Maeda T, Matsuoka K, Saito D, Miyoshi S, Matsuura M, Okamoto S, Tamura S, Hisamatsu T. Machine learning using clinical data at baseline predicts the efficacy of vedolizumab at week 22 in patients with ulcerative colitis. Sci Rep 2021;11:16440. [PMID: 34385588 DOI: 10.1038/s41598-021-96019-x] [Reference Citation Analysis]